GenVec Appoints Cynthia Collins as President and CEO 
MarketWatch (press release)
GenVec's development programs address therapeutic areas such as hearing loss and balance disorders; as well as vaccines against infectious diseases including respiratory syncytial virus (RSV), herpes simplex virus (HSV), dengue fever, malaria, ...

and more » 

GenVec Awarded Grant For RSV Vaccine Program 
MarketWatch (press release)
GenVec's development programs address therapeutic areas such as hearing loss and balance disorders; as well as vaccines against infectious diseases including respiratory syncytial virus (RSV), herpes simplex virus (HSV), dengue fever, malaria, ...

and more » 

GenVec Awarded Grant For RSV Vaccine Program 
PR Newswire (press release)
GenVec's development programs address therapeutic areas such as hearing loss and balance disorders; as well as vaccines against infectious diseases including respiratory syncytial virus (RSV), herpes simplex virus (HSV), dengue fever, malaria, ...
NIH awards SBIR grant for GenVec RSV vaccine program Pharmaceutical Business Review

all 5 news articles » 

New Study Demonstrates Dosing Non-Compliance Increases RSV-Related ... 
MarketWatch (press release)
Non-compliance with the FDA-approved dosing of Synagis® (palivizumab), defined as not receiving at least 5 doses or having dosing gaps, significantly increased likelihood of hospitalization from respiratory syncytial virus (RSV) among high-risk infants ...

and more » 

Researchers Developing Virus Barcodes 
news Stories
Researchers at the University of Leeds are developing a way to ?barcode? viral diseases, including different strains of the influenza virus and human respiratory syncytial virus (HRSV)?a virus associated with the onset of asthma in young children, ...

 

Idaho Technology Receives FDA 510(k) Clearance for Expanded FilmArray(R ... 
MarketWatch (press release)
FilmArray RP is now FDA-cleared for 20 viral and bacterial respiratory pathogens. "We are pleased to offer a more robust and simpler way to test for upper respiratory tract infections," said Kirk Ririe, Chief Executive Officer of Idaho Technology.

and more » 

GenVec Reports First Quarter 2012 Financial Results 
MarketWatch (press release)
Encouraging preclinical proof of concept data generated in non-human primates involving GenVec's respiratory syncytial virus (RSV) vaccine program were presented at Keystone Symposia's 2012 Meeting on Viral Immunity and Host Gene Influence.

and more » 

Alere Developing Pair of NAT Platforms with Initial Assays Planned for HIV ... 
GenomeWeb
The first platform, called the Alere NAT Analyzer, will enable multiplexed nucleic acid measurements from whole blood samples, initially for HIV viral load monitoring but eventually for detecting or monitoring other infectious diseases, ...

 

Idaho Technology Receives FDA 510(k) Clearance for Expanded FilmArray(R ... 
GlobeNewsWire (press release)
FilmArray RP is now FDA-cleared for 20 viral and bacterial respiratory pathogens. "We are pleased to offer a more robust and simpler way to test for upper respiratory tract infections," said Kirk Ririe, Chief Executive Officer of Idaho Technology.

and more » 

Alnylam Pharmaceuticals Reports First Quarter 2012 Financial Results 
MarketWatch (press release)
Completed Enrollment in Phase IIb Clinical Study of ALN-RSV01 for the Treatment of Respiratory Syncytial Virus (RSV) Infection. The company has completed enrollment in its Phase IIb trial with ALN-RSV and expects to report results in mid-2012.

and more »